Growth suppression of glioma cells by PTEN requires a functional phosphatase catalytic domain
- 11 November 1997
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 94 (23), 12479-12484
- https://doi.org/10.1073/pnas.94.23.12479
Abstract
Deletions of all or part of chromosome 10 are the most common genetic alterations in high-grade gliomas. The PTEN gene (also called MMAC1 and TEP1) maps to chromosome region 10q23 and has been implicated as a target of alteration in gliomas and also in other cancers such as those of the breast, prostate, and kidney. Here we sought to provide a functional test of its candidacy as a growth suppressor in glioma cells. We used a combination of Northern blot analysis, protein truncation assays, and sequence analysis to determine the types and frequency of PTEN mutations in glioma cell lines so that we could define appropriate recipients to assess the growth suppressive function of PTEN by gene transfer. Introduction of wild-type PTEN into glioma cells containing endogenous mutant alleles caused growth suppression, but was without effect in cells containing endogenous wild-type PTEN. The ectopic expression of PTEN alleles, which carried mutations found in primary tumors and have been shown or are expected to inactivate its phosphatase activity, caused little growth suppression. These data strongly suggest that PTEN is a protein phosphatase that exhibits functional and specific growth-suppressing activity.Keywords
This publication has 35 references indexed in Scilit:
- Germline mutations in the PTEN/MMAC1 gene in patients with Cowden diseaseHuman Molecular Genetics, 1997
- Germline mutations in PTEN are present in Bannayan-Zonana syndromeNature Genetics, 1997
- Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancersNature Genetics, 1997
- PTEN , a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate CancerScience, 1997
- Common alternative gene alterations in adult malignant astrocytomas, but not in childhood primitive neuroectodermal tumors: P16ink4 homozygous deletions and CDK4 gene amplificationsJournal of Neurosurgery, 1996
- Molecular genetics and molecular biology advances in brain tumorsCurrent Opinion in Oncology, 1996
- A tiger behind many doors: multiple genetic pathways to malignant gliomaTrends in Genetics, 1995
- Detection of BRCA1 mutations by the protein truncation testHuman Molecular Genetics, 1995
- Molecular genetics of human gliomaCurrent Opinion in Oncology, 1995
- Rapid Detection of Translation-Terminating Mutations at the Adenomatous Polyposis Coli (APC) Gene by Direct Protein Truncation TestGenomics, 1994